NEW YORK (GenomeWeb News) — Emory University has added one of Corning’s label-free screening systems for use in its drug discovery research programs, the company said yesterday.
The university bought the Epic System for use in its Emory Chemical Biology Discovery Center, which is part of the National Institutes of Health-funded Molecular Libraries Screening Centers Network. The MLSCN includes ten screening centers that work to develop new chemical probes for drug research.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.